Replies to post #510545 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

I get it... but then again, given what we know about DCVax-L via trial data presentations, I don't.

I understand the frustrations and irritations regarding expectations (not promises, imho) that NWBO set EXPLICITLY but did not deliver... without ever addressing the issue... and simply moved on to another different milestone. Also, there were a number expectations that retail erroneously set by misinterpreting 'signals' and tea-leaf reading.

But, despite all of the missed expectations, the data is clear: DCVax-L works. One would have to concluded the LP has more invested in NWBO, more to loose and more to gain from the success of DCVax-L. This, in addition to her 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing, more than suggests to me that any missed expectations is not intentional or due to incompetence on her part but is twist of circumstances out of her control, forcing her to adjust.

Vator, I am not trivializing your valid concerns, frustrations and disappointments. I have felt them too. But the trial has ended. The data from the phase3 trial is what we expected. This is not a time to be weary or overcome with impatience. It would be a damn shame for NWBO longs to fight for damn near 10 years to hold on to NWBO through all the bullshit only to give up just before the gains.

Stay strong....